22nd Century Group Inc (XXII) : Traders are bullish on 22nd Century Group Inc (XXII) as it has outperformed the S&P 500 by a wide margin of 38.84% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 24.79%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 25% in the last 1 week, and is up 38.1% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 27.14% and the 50-Day Moving Average is 39.95%.The 200 Day SMA reached 48.94%
22nd Century Group Inc (NYSEMKT:XXII): After opening at $1.45, the stock dipped to an intraday low of $1.39 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $1.48 and the buying power remained strong till the end. The stock closed at $1.45 for the day, a gain of 0.69% for the day session. The total traded volume was 1,629,661. The stocks close on the previous trading day was $1.45.
22nd Century Group, Inc. is a plant biotechnology company specializing in technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding. The Company is focused on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. It owns and controls around 128 issued patents and an additional 52 pending patent applications. The Companys owned or licensed patents are issued in around 96 countries. The Company focuses on licensing, manufacturing and selling its tobacco products. Its products include RED SUN and MAGIC Cigarettes, SPECTRUM Government Research Cigarettes, BRAND A and BRAND B, and X-22 Smoking Cessation Aid. The Company manufactures filtered cigar and cigarette brands of third-parties at its manufacturing facility in North Carolina.